Cargando…
A homozygous double mutation in SMN1: a complicated genetic diagnosis of SMA
Spinal muscular atrophy (SMA), the most common autosomal recessive cause of infant death, is typically diagnosed by determination of SMN1 copy number. Approximately 3–5% of patients with SMA retain at least one copy of the SMN1 gene carrying pathogenic insertions, deletions, or point mutations. We r...
Autores principales: | Kirwin, Susan M, Vinette, Kathy M B, Gonzalez, Iris L, Abdulwahed, Hind Al, Al-Sannaa, Nouriya, Funanage, Vicky L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865576/ https://www.ncbi.nlm.nih.gov/pubmed/24498607 http://dx.doi.org/10.1002/mgg3.10 |
Ejemplares similares
-
Molecular Genetic Testing for Kidney Disorders During the COVID-19 Pandemic
por: Kirwin, Susan M., et al.
Publicado: (2021) -
Functional characterization of SMN evolution in mouse models of SMA
por: Osman, Erkan Y., et al.
Publicado: (2019) -
How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein?
por: Li, Wei
Publicado: (2017) -
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
por: Hensel, Niko, et al.
Publicado: (2020) -
Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology
por: Wang, Yiran, et al.
Publicado: (2019)